|Articles|March 18, 2020
Three Key Critical Considerations Before Embarking on Decentralized Trials
Author(s)Oracle
- Clinical trials can be designed across a continuum of formats. - Adding decentralized elements to trials can help acquire high-quality data. - Sponsors must understand the impact across the trial landscape for success.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Related Content
Trending on PharmExec
1
From Evidence to Access: How Real-World Data Delivers for Patients
2
Tariff Uncertainty Drives Short-Term Manufacturing Surge as Global Pharmaceuticals Enter Fragmented Growth Phase: Report
3
Pharma Companies Raise List Prices, Including 16 That Had Agreements to Lower Prices with Trump Administration: Report
4
WHO Finalizes United States’ Withdrawal from Organization: Report
5